National Health Act 1953 Amendment determinations under sections 85, 85A and 88 pharmaceutical benefits (No. PB 81 of 2010) (Cth)

COMMONWEALTH OF AUSTRALIA

Instrument number PB 81 of 2010

Amendment determinations under sections 85, 85A and 88 of the National Health Act 1953

I, ANDREW STUART, Acting Deputy Secretary, Department of Health and Ageing, delegate of the Minister for Health and Ageing, make this instrument under sections 85, 85A and 88 of the National Health Act 1953.

Dated 3 August 2010

A Stuart

ANDREW STUART

Acting Deputy Secretary

Department of Health and Ageing

Amendment determination — pharmaceutical benefits

1              Commencement

This instrument commences on 1 September 2010.

2              Amendment of PB 68 of 2010

Schedule 1 amends PB 68 of 2010.

Schedule 1            Amendments

1. Part 1 of Schedule 1, item dealing with Amino acid formula with vitamins and minerals without methionine, threonine and valine and low in isoleucine

insert as first entries in the columns in the order indicated:

Sachets containing oral powder 25 g, 30 (MMA/PA express)	Oral	4	5	MMA/PA express
Sachets containing oral powder 20 g, 30 (MMA/PA gel)	Oral	4	5	MMA/PA gel

1. Part 1 of Schedule 1, item dealing with Amino acid formula with vitamins and minerals without phenylalanine

omit from the columns in the order indicated:

Oral powder 325 g (Phenex-2) Oral 10 5 Phenex-2

and substitute:

Oral powder 400 g (Phenex-2) Oral 8 5 Phenex-2

1. Part 1 of Schedule 1, item dealing with Amoxycillin in the form Capsule 500 mg (as trihydrate)

omit from the column headed “Brand”: Amoxycillin-DP

1. Part 1 of Schedule 1, item dealing with Ciprofloxacin in the form Tablet 250 mg (as hydrochloride)

insert in alphabetical order in the column headed “Brand”: Ciprofloxacin Sandoz

1. Part 1 of Schedule 1, item dealing with Fluconazole in the form Solution for I.V. infusion 200 mg in 100 mL

insert in alphabetical order in the column headed “Brand”: Fluconazole Sandoz

1. Part 1 of Schedule 1, after item dealing with Glucose Indicator—Blood in the form Test strips, 50 (Omnitest EZ)

insert in the columns in the order indicated:

Test strips, 50 (OneTouch Verio) For external use 2 5 OneTouch Verio

1. Part 1 of Schedule 1, item dealing with Indapamide in the form Tablet containing indapamide hemihydrate 2.5 mg

insert in alphabetical order in the column headed “Brand”: Indapamide Sandoz

1. Part 1 of Schedule 1, item dealing with Insulin Glulisine in the form Injection (human analogue), cartridges, 100 units per mL, 3 mL, 5

insert in alphabetical order in the column headed “Brand”: Apidra

1. Part 1 of Schedule 1, item dealing with Levetiracetam in the form Tablet 250 mg

insert in alphabetical order in the column headed “Brand”: Levecetam 250

1. Part 1 of Schedule 1, item dealing with Levetiracetam in the form Tablet 500 mg

insert in alphabetical order in the column headed “Brand”: Levecetam 500

1. Part 1 of Schedule 1, item dealing with Levetiracetam in the form Tablet 1 g

insert in alphabetical order in the column headed “Brand”: Levecetam 1000

1. Part 1 of Schedule 1, item dealing with Levodopa with Carbidopa in the form Tablet 250 mg-25 mg (anhydrous)

insert in alphabetical order in the column headed “Brand”: Levo/Carbidopa Sandoz

1. Part 1 of Schedule 1, item dealing with Mexiletine

omit from the columns in the order indicated:

Capsule containing mexiletine hydrochloride 50 mg Oral 100 5 Mexitil

1. Part 1 of Schedule 1, item dealing with Moclobemide in the form Tablet 150 mg

insert in alphabetical order in the column headed “Brand”: Moclobemide Sandoz

1. Part 1 of Schedule 1, item dealing with Prazosin in the form Tablet 1 mg (as hydrochloride)

omit from the column headed “Brand”: Pressin 1

1. Part 1 of Schedule 1, item dealing with Prazosin in the form Tablet 2 mg (as hydrochloride)

omit from the column headed “Brand”: Pressin 2

1. Part 1 of Schedule 1, item dealing with Prazosin in the form Tablet 5 mg (as hydrochloride)

omit from the column headed “Brand”: Pressin 5

1. Part 1 of Schedule 1, item dealing with Verapamil in the form Tablet containing verapamil hydrochloride 240 mg (sustained release)

omit from the column headed “Brand”: Anpec SR

1. Part 2 of Schedule 1, after item dealing with Glucose Indicator—Blood in the form Test strips, 50 (Omnitest EZ)

insert in the columns in the order indicated:

Test strips, 50 (OneTouch Verio) For use in patients who are receiving treatment under a GP Management Plan or Team Care Arrangements where Medicare benefits were or are payable for the preparation of the Plan or coordination of the Arrangements For external use 2 11 OneTouch Verio

1. Part 1 of Schedule 3, item dealing with Amoxycillin in the form Capsule 500 mg (as trihydrate)

omit from the column headed “Brand”: Amoxycillin-DP

Note

All legislative instruments and compilations are registered on the Federal Register of

Legislative Instruments kept under the Legislative Instruments Act 2003.

See

AI Chat Citations

Actions

Download as PDF Download as Word Document

---

Citations

National Health Act 1953 - Amendment determinations under sections 85, 85a and 88 - pharmaceutical benefits (No. PB 81 of 2010) (Cth)

---

Cases Citing This Decision

0

Cases Cited

0

Statutory Material Cited

0

Return